Alpha Tau Medical Ltd
DRTS | NASDAQ
$15.25
-$0.25 (-1.61%)
Sep 22, 2026, 12:38 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -9.34 | -6.89 | -7.14 | -6 | -14.66 | -45.91 |
PEG Ratio | -0.53 | -0.96 | 0.34 | 0.29 | -0.07 | -0.66 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 5.17 | 3.46 | 2.46 | 1.91 | -11.44 | -48.45 |
P/FCF Ratio | -12.18 | -9.84 | -8.54 | -8.15 | -27 | -37.06 |
P/OCF Ratio | -14.95 | -10.96 | -11.59 | -8.46 | -33.69 | -56.32 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.18 | 0.20 | 0.16 | 0.05 | -1.55 | -6.40 |
Quick Ratio | 7.45 | 7.40 | 12.08 | 24.55 | 9.26 | 22.73 |
Current Ratio | 7.45 | 7.40 | 12.07 | 24.55 | 7.41 | 22.73 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | -100.93 | -104.77 | 914.87 | -18.17 | -1.04 | -42.60 |
Return on Equity | -55.29% | -50.67% | -34.52% | -31.95% | 78.42% | 105.37% |
Return on Assets | -40% | -36.83% | -27.15% | -28.10% | -64.60% | -16.76% |
Return on Invested Capital | -43.50% | -45.31% | 34.84% | -27.59% | -36.47% | -18.16% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove DRTS